Genmab presents full data set for cancer drug
![Photo: Joost Melis / Genmab / PR](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article14139217.ece/ALTERNATES/schema-16_9/doc7lex7y1o6y11mhe3x80q.jpg)
On Saturday, Genmab reported all data from a successful phase II study of drug candidate epcoritamab as a treatment for large B-cell lymphoma (LBCL).
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Cancer drug hope raises Genmab's spirits after legal defeat
For subscribers
Genmab receives orphan drug designation from FDA
For subscribers